Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E8ZY
|
||||
Former ID |
DIB007692
|
||||
Drug Name |
Vapitadine
|
||||
Synonyms |
Hivenyl; Vapitadine dihydrochloride; R-129160; Vapitadine (oral), Barrier Therapeutics
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Allergic skin disorders [ICD10:L00-L99] | Phase 2 | [547977] | ||
Company |
Barrier Therapeutics Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H20N4O
|
||||
Canonical SMILES |
c12n(c(cn1)C(=O)N)CCc1c(C32CCNCC3)cccc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [547978] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.